WebMar 1, 2007 · University of Michigan: Ann Arbor, MI, US. 2007-03-01 to present associate professor (Microbiology and Immunology) Employment. Show more detail. Source : … WebFeb 17, 2024 · Viruses interact with receptors on the cell surface to initiate and co-ordinate infection. The distribution of receptors on host cells can be a key determinant of viral tropism and host infection. Unravelling the complex nature of virus-receptor interactions is, therefore, of fundamental importance to understanding viral pathogenesis. Noroviruses are non …
Prolonged SARS-CoV-2 replication in an immunocompromised patient …
WebA.E. Fischer et al. / Journal of Virological Methods 213 (2015) 111–117 113 Fig. 1. Microfluidic system. (a) Droplet formation chips contain 3 inlet ports (one for oil/surfactant and two for aqueous solutions) and one outlet port for droplet collection. WebJanelle N Stokely, 1 Sandra Niendorf, 2 Stefan Taube, 1 Marina Hoehne, 2 Vincent B Young, 1,3 Mary AM Rogers, 4 Christiane E Wobus 1 1 Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA; 2 Department of Infectious Diseases, Consultant Laboratory for Noroviruses, Robert Koch Institute, Berlin, … hugo belanger
Christiane Wobus Publications University of Michigan
WebSep 22, 2024 · Viral cultures and sequence analysis demonstrate ongoing replication of infectious SARS-CoV-2 virus for at least 119 days. The patient had three admissions related to COVID-19 over a four-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The patient’s lack of seroconversion … WebMar 7, 2003 · STAT1 –/– mice, like wild-type mice, contained MNV-1 genome in intestine, liver, and spleen one day after inoculation ( Fig. 4 D). In contrast to wild-type mice, STAT1 –/– mice had high levels of MNV-1 RNA in multiple organs, as well as substantial tissue pathology, 3 and 7 days after infection. ( Fig. 4, D and E). WebSnippet: The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated disease COVID-19, requires therapeutic interventions that can be rapidly identified and translated to clinical care. Traditional drug discovery methods have a >90% failure rate and can take 10 to 15 y from target identification to clinical use. hugo bergmann gmbh